Valuation: Malin Corporation Plc

Market Cap 30.78M 35.41M 28.65M 26.3M 49.67M 3.38B 50.44M 338M 133M 1.68B 133M 130M 5.64B P/E 2024 *
-
P/E 2025 -8.37x
Enterprise Value 17.88M 20.57M 16.64M 15.28M 28.85M 1.96B 29.3M 196M 76.99M 977M 77.24M 75.55M 3.28B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
63.83%
Yield 2024 *
-
Yield 2025 -
1 month-2.07%
3 months-10.69%
6 months-11.25%
Current year-7.79%
1 week 7.1
Extreme 7.1
7.1
1 month 7.1
Extreme 7.1
7.25
Current year 7
Extreme 7
8.45
1 year 7
Extreme 7
9.3
3 years 3.84
Extreme 3.84
10.4
5 years 3.59
Extreme 3.59
10.4
10 years 1.4
Extreme 1.4
14.4
Manager TitleAgeSince
Director of Finance/CFO 56 2022-04-30
Director TitleAgeSince
Chairman 73 2019-08-01
Director/Board Member 67 2018-07-15
Director/Board Member 63 2018-07-15
Date Insider Type Main position Quantity % Market Cap.
5/28/25 Fiscal year

Chief Executive Officer

5,746 0.1328%
4/7/25 Sell

Director

11,075 0.2560%
4/7/25 Sell

Chief Executive Officer

17,780 0.4110%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-16.47%+62.84% 35.41M
-0.53%-3.95%+50.70%+152.78% 1,024B
+0.21%-2.68%+53.20%+50.87% 618B
-2.51%-3.25%+28.54%+67.99% 443B
+0.06%-0.42%+37.53%+31.06% 349B
-0.14%-0.24%+34.41%+39.49% 297B
-0.69%-0.30%+13.76%+13.84% 264B
-7.37%-4.40%-0.74%-43.66% 209B
-0.64%+2.43%+29.74%+67.16% 208B
-0.82%+0.70%+15.05%+72.05% 162B
Average -1.24%-1.21%+24.57%+51.44% 357.38B
Weighted average by Cap. -0.99%-2.17%+37.18%+72.98%

Financials

2024 2025
Net sales - -
Net income - -6.9M -7.94M -6.42M -5.9M -11.14M -758M -11.31M -75.7M -29.71M -377M -29.81M -29.15M -1.26B
Net Debt -62.1M -71.44M -57.8M -53.07M -100M -6.82B -102M -681M -267M -3.39B -268M -262M -11.38B -12.9M -14.84M -12.01M -11.02M -20.82M -1.42B -21.14M -142M -55.55M -705M -55.73M -54.51M -2.36B
Logo Malin Corporation Plc
Malin Corporation Plc is a company investing in and supporting highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Its purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential.
Employees
2
Date Price Change Volume
26-07-31 €7.100 -.--% 750
26-07-30 €7.100 -.--% 0
26-07-29 €7.100 -.--% 0
26-07-28 €7.100 -.--% 1
26-07-27 €7.100 -.--% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.100EUR
Average target price
15.50EUR
Spread / Average Target
+118.31%